132294-17-8Relevant articles and documents
A practical asymmetric synthesis of the antiviral agent lobucavir, BMS-180194
Singh, Janak,Bisacchi, Gregory S.,Ahmad, Saleem,Godfrey Jr., Jollie D.,Kissick, Thomas P.,Mitt, Toomas,Kocy, Octavian,Vu, Truc,Papaioannou, Chris G.,Wong, Michael K.,Heikes, James E.,Zahler, Robert,Mueller, Richard H.
, p. 393 - 399 (1998)
A practical synthesis of the antiviral agent lobucavir, [1R-(1α,2β,3α)]-2-amino-9-[2,3-bis(hydroxymethyl)cyclobutyl]- 6H-purin-6-one (BMS-180194), is described. The key chiral intermediate, [1S-(1α,2β,3α)]-3-hydroxy-1,2-cyclobutanedimethanol, dibenzoate e
CYCLOBUTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS
-
, (2020/07/07)
Described herein are cyclobutyl nucleoside analogs of Formula (I), pharmaceutical compositions that include one or more cyclobutyl nucleoside analogs and methods of using the same to treat HBV, HDV and/or HIV.
Expedient approach to chiral cyclobutanones: Asymmetric synthesis of cyclobut-G
Darses, Benjamin,Greene, Andrew E.,Coote, Susannah C.,Poisson, Jean-Francois
scheme or table, p. 821 - 824 (2009/04/10)
An efficient one-pot asymmetric synthesis of cyclobutanones from chiral enol ethers is described. The approach is illustrated with alkyl- and functionalized alkyl-substituted enol ethers (nine examples). A new enantioselective synthesis of cyclobut-G (Lobucavir) could thus be achieved.